al102
ayala pharmaceuticalsceuticals,novartis
['al102', 'pivotal', 'ayala', '$ayla']
$ayla down 10.08% at $1.38 (volume 731k, avgvolume 501k) in the last 20 min latest news: 8:00 am edt today
ayala pharmaceuticalsceuticals presents positive interim data from ringside pivotal phase 2/3 trial of al102 in desmoid tumors at esmo congress 2022 
Real-time penny stock alerts based on trading algorithms and breaking news; buy the dips and sell the rips.

Visit our website for more details.